Rabbit polyclonal antibody to human C-C Chemokine Receptor type 7 (341-357): Affinity purified

Antibodies

貨號 Cat. No.
R-1044-100
規格 Size
100 µg
品牌 Brand
Biosensis
Application 應用
IH,Frozen 、 IH(P), Paraffin 、 WB
Reactivity
Human 、 Mouse 、 Rat
Host
Rabbit
Clonality
Polyclonal

Description




ZZZZ_Status (Active, Disc) : Active


 

AA_Supplier Name : Biosensis


 

Alternative_Name (Other Names) :


C-C chemokine receptor type 7; C-C CKR-7; CC-CKR-7; CCR-7; MIP-3 beta receptor;EBV-induced G-protein coupled receptor 1; EBI1; BLR2; CDw197; CD197;


 

Antibody_Isotype
(Antibody only) :


 

Application_Details :


Immunohistochemistry (IHC) and Western Blotting (WB). A concentration of 1.0-2.0 µg/mL is recommended for WB. Human CCR-7 (precursor) has a predicted length of 378 residues and MW of 43 kDa. A concentration of 1.0-2.0 µg/mL is recommended to detect the protein in formalin fixed and paraffin embedded tissues. Antigen retrieval is required. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.


 

Background_Info :


 

Clone_Name
(AB only, monoclonals) :


 

Datasheet_Link : http://www.biosensis.com/pdf_datasheet.php?products_id=515


 

Description (Long Description) : 


C-C Chemokine Receptor type 7 (CCR-7) is a G-protein coupled receptor  for the MIP-3-beta chemokine. CCR-7 expression has been found in various lymphoid tissues and activated B- and T-lymphocytes. CCR-7 is highly expressed in B-cells infected with Epstein-Barr virus (EBV) and T-cells infected with herpes virus 6 or 7.

 

Expiry_Date : 


12 months after purchase

 

Format (Form) : 


Lyophilized with 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3

 

Immunogen (Antigen) :A synthetic peptide (FKDLGCLSQEQLRQWSS) corresponding to a region (341-357) from the C-terminus of human C-C Chemokine Receptor type 7. To enhance the immunological response, this peptide was coupled to carrier protein BSA.


 

Kit_Components :


 

MSDS (File name) :


 



詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢